For those of you still in this....due to the new strategic merger between AVANT and Celldex, AVANT is terminating the collaboration with Select.
At least SLT got their money for a year but will now have to find new partners to progress vaccines further:
2-Nov-2007
Other Events
Item 8.01 Other Events. On November 1, 2007, AVANT Immunotherapeutics, Inc. (the "Company") notified Select Vaccines Limited (ASX: SLT), an Australian biotechnology company ("SLT") that, effective December 31, 2007, the Company for strategic reasons is exercising its rights to terminate its Collaboration and License Agreement with SLT.
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held